Serveur d'exploration sur les peptides biopesticides - Curation (Accueil)

Index « MedMesh.i » - entrée « Metformin »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Metarhizium < Metformin < Methacholine Chloride  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 49.
[0-20] [0 - 20][0 - 49][20-40]
Ident.Authors (with country if any)Title
000347 (2019) Ji-Chang Wang [République populaire de Chine] ; Guang-Yue Li [République populaire de Chine] ; Bo Wang [République populaire de Chine] ; Su-Xia Han [République populaire de Chine] ; Xin Sun [République populaire de Chine] ; Yi-Na Jiang [République populaire de Chine] ; Yan-Wei Shen [République populaire de Chine] ; Can Zhou [République populaire de Chine] ; Jun Feng [République populaire de Chine] ; Shao-Ying Lu [République populaire de Chine] ; Jian-Lin Liu [République populaire de Chine] ; Mao-De Wang [République populaire de Chine] ; Pei-Jun Liu [République populaire de Chine]Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation.
000560 (2018) Isabel Garcia-Martin [Royaume-Uni] ; Richard J A. Penketh [Royaume-Uni] ; Anna B. Janssen [Royaume-Uni] ; Rhiannon E. Jones [Royaume-Uni] ; Julia Grimstead [Royaume-Uni] ; Duncan M. Baird [Royaume-Uni] ; Rosalind M. John [Royaume-Uni]Metformin and insulin treatment prevent placental telomere attrition in boys exposed to maternal diabetes.
000593 (2019) Bahaa Al-Trad [Jordanie] ; Hakam Alkhateeb [Jordanie] ; Wesam Alsmadi [Jordanie] ; Mazhar Al-Zoubi [Jordanie]Eugenol ameliorates insulin resistance, oxidative stress and inflammation in high fat-diet/streptozotocin-induced diabetic rat.
000997 (2018) Puneet Gaitonde [États-Unis] ; Felipe K. Hurtado [États-Unis] ; Parag Garhyan [États-Unis] ; Jenny Y. Chien [États-Unis] ; Stephan Schmidt [États-Unis]Development and Qualification of a Drug-Disease Modeling Platform to Characterize Clinically Relevant Endpoints in Type 2 Diabetes Trials.
000B08 (2017) Julien Lamontagne [Canada] ; Anfal Al-Mass [Canada] ; Christopher J. Nolan ; Barbara E. Corkey [États-Unis] ; S R Murthy Madiraju [Canada] ; Erik Joly [Canada] ; Marc Prentki [Canada]Identification of the signals for glucose-induced insulin secretion in INS1 (832/13) β-cells using metformin-induced metabolic deceleration as a model.
000B92 (2017) Silvio E. Inzucchi [États-Unis]Is It Time to Change the Type 2 Diabetes Treatment Paradigm? No! Metformin Should Remain the Foundation Therapy for Type 2 Diabetes.
000B93 (2017) Muhammad Abdul-Ghani [États-Unis, Qatar] ; Ralph A. Defronzo [États-Unis]Is It Time to Change the Type 2 Diabetes Treatment Paradigm? Yes! GLP-1 RAs Should Replace Metformin in the Type 2 Diabetes Algorithm.
000C89 (2017) Emily B. Schroeder [États-Unis] ; Stan Xu [États-Unis] ; Glenn K. Goodrich [États-Unis] ; Gregory A. Nichols [États-Unis] ; Patrick J. O'Connor [États-Unis] ; John F. Steiner [États-Unis]Predicting the 6-month risk of severe hypoglycemia among adults with diabetes: Development and external validation of a prediction model.
000D85 (2017) Aurélien Mary [France] ; Agnes Hartemann [France] ; Sophie Liabeuf [France] ; Carole Elodie Aubert [France, Suisse] ; Salim Kemel [France] ; Joe Elie Salem [France] ; Philippe Cluzel [France] ; Aurélie Lenglet [France] ; Ziad A. Massy [France] ; Jean-Daniel Lalau [France] ; Romuald Mentaverri [France] ; Olivier Bourron [France] ; Saïd Kamel [France]Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients.
000E32 (2017) Dina M. Abo-Elmatty [Égypte] ; Eman A. Ahmed [Égypte] ; Mona K. Tawfik [Égypte] ; Seham A. Helmy [Égypte]Metformin enhancing the antitumor efficacy of carboplatin against Ehrlich solid carcinoma grown in diabetic mice: Effect on IGF-1 and tumoral expression of IGF-1 receptors.
000F42 (2016) Dongge Cai [République populaire de Chine] ; Hongli Sun ; Yanhua Qi ; Xiaogui Zhao ; Minjuan Feng ; Xiaoling WuInsulin-Like Growth Factor 1/Mammalian Target of Rapamycin and AMP-Activated Protein Kinase Signaling Involved in the Effects of Metformin in the Human Endometrial Cancer.
001051 (2016) Joanna Parkinson [Suède] ; Bengt Hamrén [Suède] ; Maria C. Kjellsson [Suède] ; Stanko Skrtic [Suède]Application of the integrated glucose-insulin model for cross-study characterization of T2DM patients on metformin background treatment.
001136 (2016) Firouzeh Dehghan [Malaisie] ; Fatemeh Hajiaghaalipour [Malaisie] ; Ashril Yusof [Malaisie] ; Sekaran Muniandy [Malaisie] ; Seyed Ali Hosseini [Iran] ; Sedigheh Heydari [Iran] ; Landa Zeenelabdin Ali Salim [Malaisie] ; Mohammad Ali Azarbayjani [Iran]Saffron with resistance exercise improves diabetic parameters through the GLUT4/AMPK pathway in-vitro and in-vivo.
001348 (2015) Shu Li ; Yun Hong ; Xin Jin ; Genbao Zhang ; Zaichang Hu ; Liuwang Nie [République populaire de Chine]A new Agkistrodon halys venom-purified protein C activator prevents myocardial fibrosis in diabetic rats.
001636 (2015) Lawrence S. Phillips [États-Unis] ; Diana Barb [États-Unis] ; Chun Yong [États-Unis] ; Anne M. Tomolo [États-Unis] ; Sandra L. Jackson [États-Unis] ; Darin E. Olson [États-Unis] ; Mary K. Rhee [États-Unis] ; Ingrid M. Duva [États-Unis] ; Qing He [États-Unis] ; Qi Long [États-Unis]Translating What Works: A New Approach to Improve Diabetes Management.
001667 (2015) Sirwan M. Hadad [Royaume-Uni] ; Philip Coates ; Lee B. Jordan ; Ryan J O. Dowling ; Martin C. Chang ; Susan J. Done ; Colin A. Purdie ; Pamela J. Goodwin ; Vuk Stambolic ; Stacy Moulder-Thompson ; Alastair M. ThompsonEvidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial.
001668 (2015) Yong-Hoon Kim [Corée du Sud] ; Jung Hwan Hwang [Corée du Sud] ; Kyoung-Shim Kim [Corée du Sud] ; Jung-Ran Noh [Corée du Sud] ; Dong-Hee Choi [Corée du Sud] ; Don-Kyu Kim [Corée du Sud] ; Surendar Tadi [Corée du Sud] ; Yong-Hyeon Yim [Corée du Sud] ; Hueng-Sik Choi [Corée du Sud] ; Chul-Ho Lee [Corée du Sud]Metformin ameliorates acetaminophen hepatotoxicity via Gadd45β-dependent regulation of JNK signaling in mice.
001B18 (2014) R. Boussageon [France] ; F. Gueyffier [France] ; C. Cornu [France]Effects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: what is the level of evidence?
001D97 (2014) Y. Liu [République populaire de Chine] ; T. HongCombination therapy of dipeptidyl peptidase-4 inhibitors and metformin in type 2 diabetes: rationale and evidence.
001E34 (2013) Zachary M. Novakovic [États-Unis] ; Matthew C. Leinung ; Patricia Grasso[D-Leu-4]-OB3, an orally bioavailable leptin-related synthetic peptide insulin sensitizer: a study comparing the efficacies of [D-Leu-4]-OB3 and metformin on energy balance and glycemic regulation in insulin-deficient male Swiss Webster mice.
001E96 (2013) Heather A. Hirsch [États-Unis] ; Dimitrios Iliopoulos ; Kevin StruhlMetformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/BiopestPeptidV1/Data/Main/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i -k "Metformin" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i  \
                -Sk "Metformin" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    BiopestPeptidV1
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Metformin
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 19:22:35 2020. Site generation: Thu Nov 19 19:33:26 2020